Califf Nomination Hearing Expected Before Holiday Season
This article was originally published in The Pink Sheet Daily
Executive Summary
Senate HELP Committee has competing priorities, but FDA commissioner nominee still seems to have smooth path to confirmation.
You may also be interested in...
Califf Nomination May Show Confidence In His Bipartisan Appeal
After seven months as deputy commissioner for medical products and tobacco, Robert Califf tapped to be FDA Commissioner.
Oral History Of Drug Development: FDA’s Califf Wants Woodcock, Temple To Share Their Stories
In an interview with “The Pink Sheet,” new deputy commissioner for medical products says FDA needs better ways of helping stakeholders, public understand agency thinking.
Senate Passes User Fee Package With Ease
Sanders casts the lone dissenting vote, saying it does not do enough to curb drug costs. Pay-for-delay and drug reimportation amendments fail.